René Russo
Chief Executive Officer at XILIO THERAPEUTICS, INC.
Net worth: 216 684 $ as of 2024-03-30
Profile
Founder of Adagio Therapeutics, Inc., René Russo presently holds the position of Chairman of Adagio Therapeutics, Inc. and President, Chief Executive Officer & Director at Xilio Therapeutics, Inc. Dr. Russo is also on the board of Celsius Therapeutics, Inc. and X4 Pharmaceuticals, Inc. (former President, Chief Executive Officer & Director). In her past career Dr. Russo was Director at Arsanis, Inc. and Vice President-Global Medical Affairs at Cubist Pharmaceuticals LLC. René Russo received a doctorate and an undergraduate degree from Rutgers Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
XILIO THERAPEUTICS INC
0.73% | 2023-12-31 | 200,633 ( 0.73% ) | 216 684 $ | 2024-03-30 |
René Russo active positions
| Companies | Position | Start |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Chief Executive Officer | 2019-05-21 |
Celsius Therapeutics, Inc.
 Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Director/Board Member | 2020-04-30 |
Xilio Therapeutics LLC
 Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Xilio Therapeutics, Inc., Xilio Therapeutics LLC develops cancer biopharmaceuticals. The private company is based in Waltham, MA. The CEO of the company is René Russo. | Chief Executive Officer | - |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - |
| Life Science Cares, Inc. | Director/Board Member | - |
Former positions of René Russo
| Companies | Position | End |
|---|---|---|
| INVIVYD, INC. | Founder | 2022-06-30 |
| X4 PHARMACEUTICALS, INC. | Chief Executive Officer | 2018-11-25 |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Chief Executive Officer | 2018-11-25 |
| CUBIST PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 2015-04-30 |
Training of René Russo
| Rutgers Business School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| XILIO THERAPEUTICS, INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Health Technology |
| Life Science Cares, Inc. | |
Xilio Therapeutics LLC
Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Xilio Therapeutics, Inc., Xilio Therapeutics LLC develops cancer biopharmaceuticals. The private company is based in Waltham, MA. The CEO of the company is René Russo. | Health Technology |
- Stock Market
- Insiders
- René Russo
